Chongqing Zhifei Biological Products Co., Ltd.

SZSE:300122 Rapporto sulle azioni

Cap. di mercato: CN¥67.6b

Chongqing Zhifei Biological Products Gestione

Gestione criteri di controllo 4/4

Chongqing Zhifei Biological Products' CEO is Rensheng Jiang, appointed in Aug 2009, has a tenure of 15.25 years. directly owns 48.44% of the company’s shares, worth CN¥33.30B. The average tenure of the management team and the board of directors is 6.3 years and 6.4 years respectively.

Informazioni chiave

Rensheng Jiang

Amministratore delegato

CN¥980.0k

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO15.3yrs
Proprietà del CEO48.4%
Durata media del management6.3yrs
Durata media del Consiglio di amministrazione6.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Share Price Boosted 45% But Its Business Prospects Need A Lift Too

Sep 30
Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Share Price Boosted 45% But Its Business Prospects Need A Lift Too

Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122) Analysts Are More Bearish Than They Used To Be

Sep 03
Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122) Analysts Are More Bearish Than They Used To Be

Calculating The Fair Value Of Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122)

Aug 23
Calculating The Fair Value Of Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122)

We Think Chongqing Zhifei Biological Products (SZSE:300122) Can Stay On Top Of Its Debt

Jul 26
We Think Chongqing Zhifei Biological Products (SZSE:300122) Can Stay On Top Of Its Debt

Why Investors Shouldn't Be Surprised By Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Low P/E

May 21
Why Investors Shouldn't Be Surprised By Chongqing Zhifei Biological Products Co., Ltd.'s (SZSE:300122) Low P/E

Earnings Miss: Chongqing Zhifei Biological Products Co., Ltd. Missed EPS By 35% And Analysts Are Revising Their Forecasts

Apr 26
Earnings Miss: Chongqing Zhifei Biological Products Co., Ltd. Missed EPS By 35% And Analysts Are Revising Their Forecasts

Is Chongqing Zhifei Biological Products (SZSE:300122) A Risky Investment?

Mar 26
Is Chongqing Zhifei Biological Products (SZSE:300122) A Risky Investment?

AMMINISTRATORE DELEGATO

Rensheng Jiang (71 yo)

15.3yrs

Mandato

CN¥980,000

Compensazione

Mr. Rensheng Jiang is Chairman of the Board & CEO of Chongqing Zhifei Biological Products Co., Ltd. from June 2002. He joined the Chongqing Zhifei Biological Products Co., Ltd.in August 2009. He is Direct...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Rensheng Jiang
Chairman of the Board & CEO15.3yrsCN¥980.00k48.44%
CN¥ 32.8b
Lingfeng Jiang
Vice Chairman & VP15.3yrsCN¥1.18m5.41%
CN¥ 3.7b
Zhen Jing Li
VP, CFO & Directorno dataCN¥1.24mNessun dato
Zhijun Wang
Chief Engineer5.6yrsCN¥1.18mNessun dato
Fei Qin
VP, Secretary of Board & Directorno dataCN¥1.18mNessun dato
Zhang Jing
Vice Presidentno dataCN¥1.24mNessun dato
Jia Liu
Assistant to the President6.3yrsCN¥920.00kNessun dato

6.3yrs

Durata media

44yo

Età media

Gestione esperta: 300122's management team is seasoned and experienced (6.3 years average tenure).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Rensheng Jiang
Chairman of the Board & CEO15.3yrsCN¥980.00k48.44%
CN¥ 32.8b
Lingfeng Jiang
Vice Chairman & VP15.3yrsCN¥1.18m5.41%
CN¥ 3.7b
Zhen Jing Li
VP, CFO & Director6.6yrsCN¥1.24mNessun dato
Fei Qin
VP, Secretary of Board & Director6.6yrsCN¥1.18mNessun dato
Xinrong Zhang
Independent Directorless than a yearCN¥67.10kNessun dato
Lin Yuan
Independent Director3.2yrsCN¥195.00kNessun dato
Xujiang Chen
Independent Director3.4yrsCN¥195.00kNessun dato
Lin Du
Non-Independent Director7.6yrsCN¥1.28mNessun dato
Shilong Yang
Non-Independent Director6.3yrsCN¥1.28mNessun dato
Yu Zhang
Employee Representative Supervisorno dataNessun dato0.000080%
CN¥ 54.1k
Tao Gong
Independent Director3.2yrsCN¥195.00kNessun dato

6.4yrs

Durata media

55yo

Età media

Consiglio di amministrazione esperto: 300122's board of directors are considered experienced (6.4 years average tenure).